Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 2 Leiomyoma 2 Inflammation 2 Frailty 2 Uterine Cervical Dysplasia 1 Squamous Intraepithelial Lesions 1 Radiodermatitis 1 Liver Neoplasms 1 Liver Cirrhosis 1 Fibrosis 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Atypical Squamous Cells of the Cervix 1

Interventions

Magnetic Resonance Spectroscopy 3 Blood Specimen Collection 3 Specimen Handling 2 Simvastatin 2 Liver Transplantation 2 tremelimumab 1 sofosbuvir-velpatasvir drug combination 1 epigallocatechin gallate 1 durvalumab 1 atezolizumab 1 apixaban 1 User-Centered Design 1 Tocopherols 1 Surveys and Questionnaires 1 Standard of Care 1 Sodium Chloride 1 Sampling Studies 1 Radiotherapy 1 Radiation 1 Pravastatin 1 Phlebotomy 1 Pharmaceutical Preparations 1 Pentoxifylline 1 Patient Navigation 1 Neuropsychological Tests 1 Musculoskeletal Manipulations 1 Memantine 1 Losartan 1 Ketoprofen 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fibrosis × epigallocatechin gallate × 1 year × Clear all

NCT07149506 2025-09-08

OCTOPUS-RD

Universidad de Guanajuato

Phase 3 Enrolling by invitation

Fibrosis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡